Renalytix Plc Asset Turnover Ratio (RNLX), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Renalytix Plc  (RNLX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Renalytix Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Renalytix Plc asset turnover ratio, the ability of Renalytix Plc's assets to generate revenue in the first quarter 2025, increased sequentially to 0.31 in the first quarter (Sep 30 2024), RNLX's balance sheet remain strong.

Within sector 27 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 2668, from total ranking in the fourth quarter 2024 at 2821.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RNLX Asset Turnover Ratio (Sep 30 2024)
I. Quarter		 (Jun 30 2024)
IV. Quarter		 (Mar 31 2024)
III. Quarter		 (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter
Y / Y Asset Change -75.03 % -75.74 % -79.66 % -65.59 % -47.15 %
Y / Y Revenue Change 13.73 % -82.78 % -26.1 % -40.52 % -52.63 %
Asset Turnover Ratio (TTM) 0.31 0.21 0.3 0.22 0.2
RNLX's Total Ranking # 2668 # 2821 # 2834 # 2813 # 0
Seq. Asset Change -36.05 % -4.06 % -21.95 % -47.86 % -37.87 %
Seq. Revenue Change -10.92 % 9.53 % -24.54 % 54.47 % -86.51 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 408
Overall Market # 2668

Asset Turnover Ratio Statistics
High Average Low
0.29 0.19 0.02
(Mar 31 2024)  




RNLX Company Profile • Back to RNLX Efficiency Comparisons • Compare RNLX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Evofem Biosciences Inc   1.33 $ 17.098  Millions$ 12.816  Millions
Viemed Healthcare Inc   1.33 $ 214.301  Millions$ 160.811  Millions
Sanuwave Health Inc   1.32 $ 29.302  Millions$ 22.149  Millions
Talkspace Inc   1.30 $ 179.853  Millions$ 138.130  Millions
Bioaffinity Technologies Inc   1.27 $ 9.368  Millions$ 7.370  Millions
Infusystem Holdings Inc  1.26 $ 132.784  Millions$ 105.399  Millions
Marpai Inc  1.26 $ 30.093  Millions$ 23.930  Millions
Adm Tronics Unlimited Inc   1.24 $ 3.146  Millions$ 2.536  Millions
Rigel Pharmaceuticals Inc  1.23 $ 157.474  Millions$ 127.893  Millions
Electrocore Inc   1.22 $ 22.458  Millions$ 18.348  Millions
Warby Parker Inc   1.22 $ 740.597  Millions$ 607.350  Millions
Hca Healthcare Inc   1.21 $ 69,621.000  Millions$ 57,502.750  Millions
Aveanna Healthcare Holdings Inc   1.21 $ 1,983.475  Millions$ 1,641.142  Millions
Henry Schein Inc   1.20 $ 12,499.000  Millions$ 10,393.500  Millions
Xtant Medical Holdings Inc   1.19 $ 112.922  Millions$ 95.251  Millions
Atara Biotherapeutics Inc   1.18 $ 174.462  Millions$ 147.692  Millions
Nrc Health  1.17 $ 144.154  Millions$ 123.561  Millions
Electromed Inc   1.17 $ 57.060  Millions$ 48.964  Millions
Koru Medical Systems Inc   1.16 $ 31.994  Millions$ 27.664  Millions
Idexx Laboratories Inc  1.15 $ 3,843.430  Millions$ 3,344.768  Millions
Regen Biopharma Inc   1.15 $ 0.237  Millions$ 0.206  Millions
Dynatronics Corporation  1.14 $ 30.784  Millions$ 27.017  Millions
Mettler toledo International Inc   1.14 $ 3,762.226  Millions$ 3,301.916  Millions
Nephros Inc   1.13 $ 12.683  Millions$ 11.191  Millions
Evolus Inc   1.13 $ 248.326  Millions$ 219.639  Millions
Vaso Corporation  1.12 $ 81.861  Millions$ 72.802  Millions
Puma Biotechnology Inc   1.12 $ 243.569  Millions$ 217.600  Millions
Sunshine Biopharma Inc   1.11 $ 32.959  Millions$ 29.651  Millions
Exagen Inc   1.11 $ 55.751  Millions$ 50.166  Millions
Medpace Holdings Inc   1.11 $ 2,070.866  Millions$ 1,864.182  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.